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Cochlear Implantation in Adults with Neurofibromatosis Type II:  
Outcomes, Benefits, and Limitations  
By  
Lydia Riehl 
Advisor: Carol A. Silverman, Ph.D., M.P.H. 
The objective of the current study was to examine, in a retrospective case series, 
outcome in terms of word-recognition performance in patients with neurofibromatosis Type 2 
(NF2) who have received a cochlear implant (CI) The primary independent variables were 
duration of deafness (DoD) and age at cochlear implantation. The secondary independent 
variables were status of hearing sensitivity in the ear contralateral to the one that received 
cochlear implantation and the type of tumor treatment.  
The retrospective case series comprised eight patients who were implanted at New York 
University Medical Center, or who were receiving follow-up care there. All NF2 patients in this 
study had an anatomically intact auditory nerve in the ear that was implanted, and were 
implanted unilaterally.  The results post implantation revealed that all eight patients achieved 
an auditory percept and were daily users of a CI. Of the 8 patients, 87.5% (7 of 8) gained open-
set speech-recognition ability. Additionally, 75% (6 of 8) of the patients were high performers, 
achieving open-set speech recognition greater than 66%.  One patient was an intermediate 
performer (33% - 66%).   
These findings were incorporated into data collected from other investigators, yielding a 
total of 36 patients with NF2 and an intact auditory nerve in the affected ear, and unilateral 




daily users of the implant, and 67% (24 of the 36) achieved some degree of open-set speech 
recognition.   
In conclusion, the results show that cochlear implantation can be a promising option for 
individuals with NF 2 who have an anatomically intact auditory nerve. No statistically significant 
relation was found between DoD or age at implantation and word-recognition scores post 
implantation. Therefore, it is difficult to predict, based on DoD or age at implantation, how well 
an individual with NF2 will do with his/her CI with regard to word-recognition performance; 
nonetheless, the probability of an auditory percept post implantation is high. Furthermore, the 
probability of gaining some degree of open-set speech recognition post implantation is 
somewhat greater than chance (about 60%).   
Key words: Neurofibromatosis Type II (NF2), Vestibular Schwannoma (VS), Cochlear implant 






Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder resulting from 
mutations in both alleles of a tumor suppression gene on chromosome 22. Individuals with NF2 
develop benign schwannoma tumors throughout the body. The most common tumors are 
spinal, intracranial, and on the vestibulocochlear nerve. The prevalence of NF2 is around 1: 
60,000 making it is a rare genetic disease (Evans, 2009). The age of onset usually is in early 
adulthood. Studies on the progression of NF2 have found the average age of onset to be about 
20 to 25 years (Evans, 2009). Individuals who have NF2 with a more severe phenotype tend to 
have earlier onset of the disorder than individuals who have NF2 with a mild phenotype.   
  A hallmark of NF2 is vestibular schwannoma (VS) growth on both auditory nerves, 
occurring in 90-95% of patients (Roehm et al. 2012). The associated hearing loss, usually 
unilateral, is accompanied by tinnitus. The growth of these tumors eventually leads to bilateral 
sensorineural hearing loss, and often deafness. Vestibular symptoms, such as imbalance and 
dizziness, also can present as initial symptoms, but these symptoms often do not persist (Evans, 
2009). Current management techniques for VS include surgical resection, stereotactic 
radiosurgery (e.g., gamma knife) and conservative monitoring (i.e., watchful waiting).  
Otologists who perform surgical resection of VSs have become very skilled at preserving 
the anatomy of the vestibulocochlear and facial nerves; nonetheless, preserving hearing is very 
difficult to accomplish. The findings of previous investigations indicate that hearing 




preservation of the cochlear nerve is possible in approximately 80% of patients (Carlson et al., 
2013). Aural rehabilitation for NF2 patients post tumor removal is a challenge because of the 
severity and nature of the hearing loss. Although VSs are benign, removal or radiation often is 
necessary to prohibit further growth into the internal auditory canal and damage to inner ear 
structures. Patients with NF2 often will develop severe to profound bilateral hearing loss after 
tumor treatment. Traditional options for these patients have included hearing aids and auditory 
brainstem implants.   
Auditory brainstem implants (ABIs) bypass the vestibulocochlear nerve and directly 
stimulate the cochlear nucleus in the auditory brainstem using a series of electrodes. When 
introduced 30 years ago, ABIs became the first prosthetic device used in auditory rehabilitation 
of NF2 patients.  Many medical and audiological professionals then presumed that an ABI was 
the only feasible option for these patients. Often, surgeons would place an ABI currently with 
resection of the VS if they felt that residual hearing could not be preserved during the resection 
(Carlson et al., 2013).  
Investigators have compared outcomes of patients with NF2 who use a CI versus those 
with NF2 who use an ABI. The results indicate that open-set speech understanding is more 
probable in the former than in the latter (Vincenti, Pasanisi, Guida, Trapani, & Sanna, 2007). In 
many cases, the best achievable outcomes of an ABI include environmental sound awareness 
and assistance in lip-reading. In addition, CI surgery is more advantageous than ABI surgery. The 
former requires less time in the OR than the latter and is a more standardized procedure than 
the latter. Additionally, ABI surgery is much more complex and presents greater surgical risks 




exceeds that for those who do ABI surgery. Because of the many advantages of a CI, a patient 
who has an intact cochlear nerve and no contraindications should first consider CI surgery 
before considering ABI surgery, particularly as it is unlikely that the patient will develop speech 
recognition with an ABI. If a CI is unsuccessful, that is, it fails to produce sound awareness, then 
an ABI subsequently can be considered.  
Over the past ten years, researchers at an increasing number of CI centers have studied 
the outcomes of patients with NF2 who receive a CI. In a multi-center retrospective study by 
Lustig et al. (2006), outcomes of seven patients with NF2 from Johns Hopkins, Mayo Clinic, and 
Stanford CI centers were examined. Of these seven patients, three had residual hearing in the 
contralateral ear and four had bilateral, severe to profound sensorineural hearing loss.  All 
seven patients had auditory perception with the CI. Three of the seven patients with a CI 
achieved open-set speech recognition. Although the results may seem disappointing compared 
to the results in adults without NF2 who receive CIs, they were quite promising because every 
patient in this subset achieved auditory perception. All seven patients had VSs with attempted 
preservation of the cochlear nerve, and these results confirm that cochlear nerve function still 
exists for these patients and can be exploited. 
Roehm et al. (2012), at the New York University Medical Center and Cochlear Implant 
Center, sought to determine whether 7 patients with NF2 who received a CI could obtain open-
set speech recognition. Of the 7, 5 had the tumor surgically removed, 1 underwent radiation, 
and 1 one underwent monitoring for a small tumor. Of the 7, 4 achieved open-set speech 
discrimination, and 6 were daily users of the CI and felt that the CI was beneficial. Thus, Lustig 




speech recognition. The more compelling case for implantation, however, was that in both 
studies, about 90% of patients reported subjective benefit from the CI and were daily CI 
wearers. Although the sample size of these studies is small, the results of these studies show 
promising benefit from cochlear implantation.  
Perhaps the most comprehensive paper thus far on the topic is a retrospective case 
series and systematic review paper by Carlson et al. (2013). The case study comprised 10 
patients ranging in age from 25 to 67 years. Of the 10, 5 underwent microsurgical resection of 
the ipsilateral tumor, 4 underwent stereotactic radiosurgery, and 1 underwent tumor 
monitoring. The duration of deafness (DoD) (the length of time that the hearing loss has been 
severe to profound in degree) among these patients ranged from 0 to 7 years. Additionally, one 
patient had significant ossification of the cochlea and another had tumor growth within the 
cochlea. Despite these additional symptoms, full insertion of the electrode array into the 
cochlea during cochlear implantation was achieved in all, and all were fit with the most up-to-
date processor. Of these 10 patients, 9 achieved sound awareness, 6 achieved open-set speech 
recognition, and 7 were daily users of the CI.    
Carlson et al. (2013) also evaluated the findings across the various investigators on all 
patients with NF2 who received a CI. Analysis of their systematic review, based on a total 
sample of 43 patients, including their 10 patients, revealed that open-set speech recognition 
was achieved in 65% of patients receiving surgical resection, 80% of patients who underwent 
stereotactic radiation, and in the 2 patients who were followed with conservative monitoring. 
The results trended toward better performance on open-set speech recognition for the patients 




did not reach statistical significance. Notably, the sample size of patients receiving stereotactic 
radiation was much smaller (N = 10) than that for those receiving surgical resection (N = 31). 
The effects of variables such as DoD, promontory stimulation results, and contralateral hearing 
on speech recognition also were examined. The results revealed that patients with a DoD less 
than ten years were statistically more likely to achieve open-set speech recognition and have 
successful telephone usage than patients with a DoD greater than ten years. Overall, Carlson et 
al. found that prolonged auditory deprivation, cochlear ossification, unfavorable promontory 
stimulation, and useful contralateral hearing were associated with poor CI performance. 
Interestingly, the better a patient’s contralateral hearing sensitivity, the more difficulty the 
patient had in acclimating to the sound quality of the CI and in using it regularly.   
Research on adults (non-NF2 etiology) receiving a CI has shown DoD to be a primary 
factor related to outcome. That is, the findings tended to reveal an inverse relation between 
DoD or magnitude of hearing loss, on the one hand, and speech-perception score, on the other 
hand. For example, Holden et al. (2013) reported that patients with a DoD not exceeding five 
years performed significantly better than those with a duration of deafness exceeding five 
years. The mean DoD in the study was 13.1 years. Some researchers also have demonstrated 
that age at cochlear implantation is a contributing factor to speech-recognition outcomes. 
Nonetheless, age at implantation is not a conclusive factor in speech-recognition outcome; 
rather, it is a variable to be considered in implantation.   
A common theme within the literature on NF2 and CI is that although open-set speech 
recognition is not always possible—it is achievable in 50-70%--it is likely that such patients with 




The high probability of auditory percept, and significant possibility for speech recognition make 
a CI an appealing option for patients with NF2.   
Purpose: 
The primary purpose of this retrospective investigation is to examine auditory 
perception outcomes of eight patients with NF2 from New York University Cochlear Implant 
Center. Additionally, the data from these patients will be incorporated into Carlson’s et al.’s 






 Institutional Review Board (IRB) approval of this retrospective chart study was obtained 
from City University of New York and from the New York University Cochlear Implant Center.   
Under the IRB approval at the latter site, each patient had signed a formal agreement at the 
time of surgery to allow his/her data to be used for research purposes. The data were de-
identified and were collected from the medical charts. Data on independent variables such as 
DoD, hearing-aid use in the contralateral ear, word-recognition performance pre-cochlear 
implantation, and on the dependent variable (word-recognition performance post cochlear 
implantation) were collected. The score on the dependent variable was based on performance 
on the Consonant-Nucleus-Consonant (CNC) word-recognition test. This medical chart review 
yielded data from 8 patients who received a CI at New York University Cochlear Implant Center 
from 1997 to 2016.  
The data also were analyzed based on the data on 26 patients in Carlson et al.’s (2013) 
systematic review along with the eight patients unique to this paper from New York University 
Medical Center and Cochlear Implant Center. Thus, the number of patients in this larger data 
set was 36; the speech-recognition material that was common to all 36 patients was CNC 
words. Notably, Carlson et al.’s data set was based on 43 patients, but only 26 of these 43 
patients were included for this study because those 26 patients had documented CNC word 
scores post-implantation. The independent variables examined included age at cochlear 
implantation, DoD, and status of hearing in the contralateral ear. The dependent variable was 




open-set word- or sentence-recognition ability, patients were classified as high performing (67-






New York University Cochlear Implant Center Data Set 
 For the smaller data set, based on the 8 patients (4 females and 4 males) with NF2 from 
New York University, who received a unilateral CI during the past 20 years, the median age was 
50 years, with a range of 33 to 65 years. The median DoD in the implanted ear was 2.1 years, 
with a range of .42 years to 20.5 years. Figure 1 shows a histogram of the DoD among the 8 
patients.  
 
Figure 1. Histogram of DoD among the 8 patients from New York University (NYU). 
Inspection of this figure reveals that 62.5% had a DoD between 0.42 years and 2.2 years. The 




hearing loss becomes severe to profound), based on the patient’s subjective report as noted on 










Figure 2. Histogram of Duration of Hearing Loss (in years). 
As can be seen from this figure, the duration of hearing loss was 2 to 10 years in 75% of the 
patients. Duration of hearing loss typically was longer than duration of deafness, as hearing loss 
often occurs progressively from the onset of NF2, and deafness often results after tumor 
treatment.   
Of the 8 patients, 5 patients underwent surgical resection of the VS, 1 underwent 
gamma knife surgery (single dose), and 2 received conservative monitoring of the VS.  (Notably, 
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implanted ear.) All eight patients had full insertion of the electrode array and acceptable 






Table 1  








































(Avastin) Yes Nucleus 512 N5 CP810 
Yes 
3 38 F Resection 5 0.42 No Yes Freedom CA N6 CP910 No 
4 56 M Resection 13 10.8 No NA2 MScala 90k Naida Q70 Yes 
5 46 F Monitoring 10 10 No NA Contour Adv. N6 CP910 NA 








8 34 M Resection 2 0.42 No Yes Nucleus 512 N5 CP810 Yes 
1HL =Hearing loss  
2NRTS = Neural Response Thresholds 
2F = Female 
3M = Male 










Table 2  

















recognition score (in 
quiet) 
1 100 100 0% 15% NA4 
2 89 85 0% 0% 0% AzBio 
3 100 100 0% 0% NA 
4 46 36 8% 31% 4% AzBio 
5 120 120 0% 0% 0% AzBio 
6 97 120 0% 0% 0% HINT 
7 50 45 18% 43% 42% AzBio 
8 77.5 35 2% 12% 0% HINT 
14 frequency pure tone averages (500, 1000, 2000, and 4000 Hz) 
2CNCw = CNC word score 
3CNCp = CNC phoneme score 




































1 12 25 Yes 76% NA4 NA Yes HP5 
2 3 17.5 Yes 58% 79% 85% AzBio Yes HP 
3 120 25 Yes 88% NA NA Yes HP 
4 3 NA Yes 10% 27% 50% HINT Yes IP 
5 12 NA Yes 60% 76% 77% AzBio Yes HP 
6 120 37.5 Yes 44% 69% 91% HINT Yes HP 
7 6 32.5 Yes 34% 64% 72% AzBio Yes HP 
8 87 NA No NA NA NA Yes NA 
14 frequency pure tone averages (500, 1000, 2000, and 4000 Hz) 
2CNCw = CNC word score 
3CNCp = CNC phoneme score 
4NA = Not applicable 




Median length of follow-up post cochlear implantation was 12 months, with a range of 3 
to 120 months. The median CNC word-recognition score was 51%, with a range of 0 – 88%. Of 
the 8 patients, 6 had CNC phoneme scores; the median CNC phoneme score was 64%, with a 
range of 0 to 79%. Sentence testing using the Hearing in Noise test (in quiet) and the AZ Bio 
Sentence Test (in quiet), was conducted in 6 of the 8 patients; in these patients, the median 
score was 72%, with a range from 0 to 91%.  
Of the eight patients, seven obtained open-set speech recognition post-implantation.  
All eight of the patients reported being daily users of the implant (see Table 2). Of the 8 
patients, 6 were high performers, 1 was an intermediate performer, and 1 was a low performer.  
A scatterplot of CNC word scores in percent as function of duration of deafness in years is 
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Figure 3. Scatterplot of CNC word score as a function of DoD Among NYU Patients 
A scatterplot of CNC word scores in percent as a function of age at implantation in years 
















Figure 4. Scatterplot of CNC word score as a function of age. 
Inspection of this scatterplot reveals no relation between these variables. This finding is 
similar to data observed by Leung et al. (2005) for patients between 33 and 65 years of age; 
Leung et al., however, did not have patients who were more than 65 years of age. On the other 
hand, Mahmoud and Ruckenstein (2014) reported significantly higher AzBio and CNC scores in 
their group of patients who were more than 65 years of age than in their group of patients who 
were less than 65 years of age.  






































  Of the 8 patients, 6 became high performers, 1 became an intermediate performer, and 
1 failed to achieve open-set speech recognition. All eight patients, however, were daily users of 
the CI and reported obtaining benefit from use of the CI. Interestingly, the high performers 
included the two patients with conservative monitoring and the one patient who received 
gamma knife treatment for the tumor. Carlson et. al (2013) found that patients receiving 
stereotactic radio surgery trended towards better performance than those receiving surgical 
resection, although this difference did not reach statistical significance.   
Combined Data Set Based on 36 Patients (8 from New York University and 26 from Carlson et al., 
2013) 
Mean age at implantation was 41.5 years, with a standard deviation of 14.7 years, and 
range of 15 to 67 years. It is unsurprising that the age of onset is higher in younger adults and 
adults not more than 65 years of age, than in adults more than 65 years of age, as the onset of 
NF2 usually is in the third and fourth decades of life. Gender distribution was similar, with 19 
males and 17 females. The mean DoD was 4.0 years, with a standard deviation of 6.7 years, and 
range of 0.3 to 26 years. The majority of patients had a relatively short DoD not exceeding 2 










Figure 5. Histogram of DoD Among Review Patients (in years) 
A short DoD among many patients is likely because tumor treatment can cause an immediate or 
quick progression in hearing loss, leaving the individual to pursue an auditory rehabilitation 
options.  
Mean length of follow-up for these patients was 40 months, with a standard deviation 
of 38.2 months, and a range of 2 to 120 months. The mean CNC word score was 34.0%, with a 
standard deviation of 31.3 percent, and a range from 0% to 88%. Some degree of open-set 
speech recognition, largely based on the AZBio or HINT in quiet, was achieved in 67% of the 
sample. The mean sentence-recognition score was 48.2%, with a standard deviation of 39.4% 
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 A scatterplot of the CNC word score in percent as a function of duration of deafness is 
shown in Figure 6.  
 
Figure 6. Scatterplot of CNC word score as a function of DoD Among Review Patients 
Inspection of this scatterplot reveals the absence of a linear relation between these variables. 
Inspection of this scatterplot also shows that the distribution of DoD appears to be skewed; the 
majority had a duration of deafness that was less than 2 years. Among the patients with a DoD 
that was greater than 2 years (N = 10), only 3 achieved CNC word-recognition scores greater 
than 20%. In comparison, among the 26 patients with a DoD not exceeding 2 years, 69% 
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Duration of Deafness (DoD) and High Performers (HP) versus Intermediate Performers (IP) 
  
Short DoD (≤ 2 years) 
 
Long DoD > 2 years 
Total number of patients 26 10 
Number of IP or HP 18 3 
Percent (%) of IP or HP 69 30 
 
Inspection of Table 4 reveals that the group with a shorter DoD has a greater chance of 
becoming intermediate or high performers than the group with a longer DoD. Nearly 70% of the 
patients with a shorter DoD had considerable speech understanding post cochlear implantation 
versus approximately 30% of the group with a longer DoD. But the difference was not 
statistically significant, probably because of the small sample size for the group with the longer 
DoD. 
 The scatterplot of CNC word score as a function of age at implantation fails to reveal a 






Figure 7. Scatterplot of CNC word score as a function of age at implantation. 
Holden et al. (2013) reported that when age at implantation exceeds 65 years, the relation 
between age at implantation and word-recognition score becomes inverse. The results of 
studies on this relation, however, are inconclusive (Budenz et al., 2011, Carlson et al., 2013, 
Friedland et al., 2010). The sample of patients in the present study (see Tables 5, 6, 7) was 
mostly under the age of 65 years, with only 3 patients over 65 years. Thus, unsurprisingly, no 
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study 1 65/F3 20.5 12 Yes 76% NA4 HP Yes 
 2 33/M
5 2 3 Yes 58/79% 89% AzBio HP Yes 
 3 38/F 0.4 120 Yes 88% NA HP Yes 
 4 56/M 10.8 3 Yes 10/27% 50% HINT IP Yes 
 8 34/M 2 87 No 0% NA NA Yes 
Carlson et 
al. 1 67/M 0.3 60 Yes 22% w 32% AzBio LP Yes  
 2 46/M 1 80 Yes 30%/58% 47% AzBio IP Yes  
 3 65/F 26 47 No 0% NA  Yes  
 4 25/F 0.3 38 No 0% NA  No 
 5 55/M 21 32 No 0% NA  Yes  
Roehm et 
al.  1 30/M 0.3 120 Yes 50/69 % HINT 89% HP Yes 
 2 22/M 11 12 No 0% 0%  Yes 
 5 27/M 0.5 2 No 0% 0%  Yes 
 6 38/F 1.4 15 Yes 80%   Yes 
 7 19/F 3 16 No 0% NR  No 
Vincenti et 
al. 1 47/F 0.3 12 Yes 80% 90% HP Yes 
 2 24/F 0 12 Yes 72% 81% HP Yes 
 3 32/M 0.3 12 Yes 50% 50% IP Yes 
 4 36/M 0.3 12 No 10% 0%  Yes 
































 3 59/F 6 60 Yes  * 96% HINT HP Yes 
 4 38/M 0.25 96 Yes  * 83% HINT HP Yes 
 5 37/F 0 60 Yes  * 96% HINT HP Yes 
 6 31/F 0.17 156 No * 22% CID  Yes 
Lustig et al.  1 35/M 0.42 28 No 0% 0% * Yes  
 2 51/M 0.42 40 Yes 79%  HP Yes  
 3 16/M 1.08 30 No  0% 0% * Yes  
 5 28/F 0.33 88 No 0% 0% * Yes  
 7 57/F 8 9 Yes 12%/35% HINT 98%  LP Yes  
1CNCw = CNC word score; CNCp = CNC phoneme score 
2HP = high performing; IP = intermediate performing; LP = low performing 
3F = Female 
4NA = Not applicable 





































Present Study 7 55/M3 2 6 Yes 34/64% 72% AzBio HP Yes 
Carlson et al. 6 50/M 1.8 22 Yes 46/67% 95% HINT HP Yes 
 7 61/M 1 56 Yes 86/93% 95% AzBio HP Yes 
 8 44/F4 2 25 Yes perception perception NA  Yes 
 9 37/M 14.8 12 No NA5 NA NA  No 
Roehm et al. 4 60/F 1 36 Yes 68/87% 58% HINT HP Yes 
Lustig et al.  4 41/F 3 17 Yes 46% NA LP Yes 
1CNCw = CNC word score; CNCp = CNC phoneme score 
2HP = high performing; IP = intermediate performing; LP = low performing 
3M = Male 
4F = Female 







Table 7  
Review Data: Conservative Monitoring Patients  
Study Patient 

























study 5 46/F3 10 12 Yes 60/76% 77% AzBio HP Yes 
 6 53/F 2 120 Yes 44/68% 72% AzBio HP Yes 
Carlson et al.  10 32/F 0.58 97 Yes 28/51% 63% HINT IP Yes 
Roehm et al.  3 53/F 0.92 24 Yes 34/53% 96% HINT HP Yes 
1CNCw = CNC word score; CNCp = CNC phoneme score 
2HP = high performing; IP = intermediate performing; LP = low performing 





 The objective of this study was to examine speech-perception outcomes among 
individuals with NF2, and also to determine if certain variables, such as DoD, age at 
implantation, etc., had significant effects on speech-perception scores. Of the 8 patients with 
NF2 and a CI examined from the New York University Cochlear Implant Center, 7 (88%) 
achieved open-set speech recognition and 8 were daily users of the implant. In the larger data 
set of 36 patients, 24 (67%) achieved open-set speech recognition and 33 patients (92%) 
reported being daily users of the implant.  
 For both the data set based on 8 patients and the larger data set based on 36 patients, 
no significant relation was observed between age at implantation and CNC word score or 
between DoD and word score. Of the 36 patients in the larger data set, 26 (about 72%) had a 
DoD not exceeding 2 years, suggesting that the distribution of DoD was skewed. Based on the 
larger data set, when speech-recognition performance for the group with short DoD (≤ 2 years) 
was compared was compared with that for the group with longer DoD (> 2 years), the 
probability of achieving intermediate or high performance on speech-recognition testing was 
higher in the former than latter group. The results from the smaller and larger data sets align 
closely with the results of other research studies on NF2 and CI.   
Limitations of this investigation included a small sample size for the data set based just 
on the patients who were implanted at New York University Medical Center and Cochlear 
Implant Center. The addition of these data to the patient data from Carlson et al.’s systematic 




small sample size. Despite this larger sample size, the sample lacked diversity on certain 
variables. For example, DoD was short for most of patients. Among the 10 patients 
(approximately 28%) with a DoD greater than 2 years, the DoD spanned a wide range from 3 
years to 26 years.  
Also, most patients (N = 25) in the larger data underwent surgical resection of the VS 
prior to CI surgery.  Only 7 patients underwent radiation and only 4 underwent conservative 
monitoring of the tumor. Future studies are needed to examine the effect of tumor treatment 
(vestibular resection versus stereotactic radiation versus conservative monitoring) on speech-
recognition outcome. Carlson et al. (2013) found that those undergoing radiation therapy 
trended towards better performance, but this result failed to reach statistical significance.  
This study was retrospective in nature, and thus relied on the accuracy and availability 
of data in patient charts and data reported on in other studies. The material employed for the 
speech-recognition measure was variable among the patients; the only consistent measure 
employed was the CNC word-recognition test. Future research should examine other speech-
recognition outcomes such as performance for phonemes and sentence-recognition materials. 
For example, only 17 of the 36 patients had sentence-recognition scores available; sentence-
recognition scores help to further classify patients as high performers, intermediate 
performers, or low performers.   
Other independent variables not examined in this investigation that may influence 
speech-recognition outcomes include tumor size, tumor location, and cochlear ossification.  




recognition performance. Carlson et al. (2013) and Roehm et al. (2012) failed to find a 
significant relation between ipsilateral tumor size and speech-recognition performance with a 
CI. Limited research has been conducted on the effect of tumor size on speech-recognition 
outcome so further research is needed to examine the relation between these variables. Future 
research also is needed to examine the effect of tumor location (with respect to proximity to 
the cochlea) on speech-recognition outcome. Tumors in patients with NF2 tumors tend to 
develop in the cerebellopontine angle and grow from the Schwann cells of the 
vestibulocochlear nerve. Sometimes, however, the tumor can develop closer to the cochlea so 
further growth can damage the spiral ganglion cells or the cochlea itself.  
In addition, cochlear ossification of the cochlea may be another independent variable to 
be considered. No patient in the smaller data set had cochlear ossification and every patient 
had a full-insertion of the electrode array. In the review data set of 36 patients, the effect of the 
variable of cochlear ossification was not reported since this data was not available from Carlson 
et al. (2013).  Roehm et al. (2012) reported that two of the three patients who failed to develop 
open-set speech after cochlear implantation had cochlear ossification. Given the sparse data on 
the effects of cochlear ossification on speech-recognition outcome in patients with NF2 and CI, 
future research is needed on this topic.  
The status of the auditory nerve is another important factor to consider.  Electrical 
promontory stimulation is employed in patients with little to no residual hearing post tumor 
treatment to determine nerve function. It may be assumed that patients with better 
performance from a CI have a more intact auditory nerve than those who did not develop 




speech-recognition performance after implantation, the probable etiology of hearing loss was 
vascular compromise to the cochlea rather than neuronal injury.  Interestingly, those with 
radiation treatment trended towards better performance than those receiving surgical 
resection in this study and in previous research. Through histological studies of temporal bones, 
researchers have surmised that radiation affects the vascular endothelial cells supplying the 
tumor rather than the VS cells. Additionally, the cochlear artery, the main blood supply to the 
cochlea, often is vulnerable to the effects of radiation and other trauma. Radiation may damage 
the stria vascularis and outer hair cells (while leaving the spiral ganglion cells intact), thereby 
resulting in progressive hearing loss (Carlson et al., 2013).       
Ossification of the cochlea is an important factor to consider when considering cochlear 
implantation in patients with NF2.  Among the eight patients from NYU Medical Center, no 
cochlear ossification was reported and every patient had a full-insertion of the electrode array. 
In the larger data set of thirty-six patients, ossification was not a variable reported on in the 26 
patients from the Carson et al. (2013) study. It appears likely that ossification would negatively 
affect performance outcomes. Roehm et al. (2012) reported that two of the three patients who 
did not develop open-set speech recognition post implantation had cochlear ossification.  
Additionally, these patients had a long time interval from VS resection to cochlear implantation.   
Length of follow-up is another variable to consider when evaluating speech-recognition 
outcome in patients with NF2 and cochlear implantation.  Length of follow-up in this study 
ranged from 3 to 120 months. With the complications among NF2 patients and the delayed 
effects of treatment, there has been concern of deterioration in performance. Carlson et al. 




who was implanted 20 years after undergoing high-dose radiation experienced a decline in 
performance at approximately one year after implant activation. The other patient who 
experienced decline in speech-recognition performance had undergone gamma knife 
treatment, CI placement, and then tumor growth necessitating surgical resection of the tumor 
and CI removal. Therefore, further longitudinal research is needed to determine long-term 
viability of CI in the NF2 population.   
Although the number of individuals with NF2 is relatively small, the research findings 
may be illuminating for other patients with acoustic neuromas. The current candidacy 
guidelines for cochlear implantation in adults is bilateral moderate to profound hearing loss, 
with speech-recognition score less than 50% in the ear to be implanted, and no greater than 
60% speech-recognition score in the opposite ear or binaurally1.  Nonetheless, the number of 
off-label cochlear implantations has been growing and recently includes patients with single-
sided deafness and neural hearing loss. Acoustic neuromas account for 8% of all cranial lesions 
and often are unilateral. Treatment for an acoustic neuroma often results in sensorineural 
hearing loss. As candidacy for CI becomes more lenient, and as more patients with bilateral VS 
show benefit with a CI, a CI may become a standard rehabilitative option for non-NF2 patients 
with single-sided deafness or asymmetric hearing loss from an acoustic neuroma. 
  






 In conclusion, cochlear implantation is a favorable option for individuals with NF2 who 
have an anatomically intact auditory nerve.  Although speech perception after implantation is 
not guaranteed, those with a shorter DoD (less than 2 years) tend to achieve better open-set 
speech recognition than those with a longer DoD (at least 2 years).  Also, patients with radiation 
therapy or conservative monitoring for a VS may do better with a CI because the auditory nerve 
tends to be intact after these procedures. Even if open-set speech recognition is not an 
outcome, it is very likely the patient will gain subjective benefit from the CI and wear it 
regularly. If a CI does not provide sufficient benefit for a patient, then an ABI still represents an 
option in management. Auditory rehabilitation in the NF2 population is difficult, and each 
patient presents unique challenges. If the auditory nerve can be preserved, even slightly, then a 
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